Dr. Charles Cox is a surgical oncologist at the University of South Florida (USF), since 1983. He completed his medical school training at the University of Utah followed by surgical residency and two years of surgical oncology fellowship at Duke University. The Comprehensive Breast Cancer Program at the University of South Florida was initiated in 1984 under his direction. In 1986, he moved the program to the Moffitt Cancer Center & Research Institute at the University of South Florida. Dr. Cox and his colleagues spearheaded the research and training in the technique for Lymphatic Mapping and Sentinel Lymph Node Biopsy in breast cancer patients. Along with pathology colleagues, they developed the Intra-Operative Touch Preparation Cytology for the evaluation of surgical margins. Dr. Cox has been recognized within the local and national press and was honored by his colleagues as a “doctor’s doctor”, is listed in Who’s Who in America and sited in the Best Doctors in America, Southeast Region. In 1999 he was named Physician of the year at the Moffitt Cancer Center. Dr. Cox is also the Principle Investigator of Agendia’s Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I (MINT) Trial. The MINT Trial is designed to test the ability of MammaPrint® in combination with TargetPrint®, BluePrint®, and TheraPrint®, as well as traditional pathologic and clinical prognostic factors, to predict responsiveness to neo-adjuvant chemotherapy in patients with locally advanced breast cancer (LABC).
Dr. Mark Gittleman is a practicing breast surgeon in Allentown, PA where he is the Medical Director of Breast Care Specialists and Advanced Breast Care Imaging. He is a past President of the American Society of Breast Surgeons, and serves on the ASBS Coding and Reimbursement and Breast Imaging Technology committees and is a review for Ultrasound and Stereotactic certification applicants. Dr. Gittleman is frequently an invited speaker on image-guided breast surgery and other breast cancer related topics. He is a faculty member of the ACS Post-Graduate courses related to breast imaging and minimally-invasive biopsy techniques.
Dr. Stephanie Akbari is the Medical Director of the Center for Breast Health at Virginia Hospital Center with an expertise in breast surgery. A Phi Beta Kappa graduate of Mount Holyoke College and a graduate of the University of Pennsylvania School of Medicine, Dr. Akbari completed her surgical internship, residency, and chief residency at Harvard Medical School’s Beth Israel Deaconess Hospital, followed by a two-year National Institutes of Health Research Fellowship. Prior to opening her distinguished private practice, Dr. Akbari was on the faculty of the Lahey Clinic in Massachusetts, where she worked as a full-time breast surgeon at the Lahey Clinic Breast Center. As the first female surgeon in Northern Virginia dedicated exclusively to diseases of the breast, Dr. Akbari has been integral in the implementation of minimally invasive techniques for the diagnosis of breast disease, such as in-office ultrasound-guided breast biopsy. She has incorporated the most advanced and newest approaches for breast cancer treatment, including sentinel node biopsy, accelerated partial breast radiation, and oncoplastic surgical techniques. She was the first surgeon in Northern Virginia to be certified by the American Society of Breast Surgeons in breast ultrasound. Dr. Akbari is Board Certified by the American Board of Surgery, a Fellow of the American College of Surgeons and a member of the American Society of Breast Surgeons.